Compare · CHE vs EUDA
CHE vs EUDA
Side-by-side comparison of Chemed Corp (CHE) and EUDA Health Holdings Limited (EUDA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CHE and EUDA operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- CHE is the larger of the two at $6.02B, about 137.7x EUDA ($43.7M).
- EUDA has been more active in the news (7 items in the past 4 weeks vs 3 for CHE).
- CHE has more recent analyst coverage (6 ratings vs 0 for EUDA).
- Company
- Chemed Corp
- EUDA Health Holdings Limited
- Price
- $455.84+0.74%
- $15.02-16.60%
- Market cap
- $6.02B
- $43.7M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 3
- 7
- Recent ratings
- 6
- 0
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Latest CHE
- SEC Form 11-K filed by Chemed Corp
- Director Lindell Andrea R sold $602,554 worth of Capital Stock (1,347 units at $447.33), decreasing direct ownership by 23% to 4,578 units (SEC Form 4)
- Roto-Rooter Buys Franchise Territory in Corpus Christi, Rio Grande Valley, and Beaumont, Texas
- Director Walsh George J Iii sold $218,915 worth of Capital Stock (500 units at $437.83), decreasing direct ownership by 13% to 3,209 units (SEC Form 4)
- Chemed Corp filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Walsh George J Iii was granted 386 units of Capital Stock, increasing direct ownership by 12% to 3,709 units (SEC Form 4)
- Director Mount John Meredith Jr. was granted 386 units of Capital Stock, increasing direct ownership by 42% to 1,316 units (SEC Form 4)
- Director Mccarthy Eileen P was granted 386 units of Capital Stock, increasing direct ownership by 45% to 1,241 units (SEC Form 4)
- Director Lindell Andrea R was granted 386 units of Capital Stock, increasing direct ownership by 7% to 5,925 units (SEC Form 4)
- Director Heaney Christopher J was granted 386 units of Capital Stock, increasing direct ownership by 16% to 2,775 units (SEC Form 4)
Latest EUDA
- SEC Form 424B5 filed by EUDA Health Holdings Limited
- SEC Form 6-K filed by EUDA Health Holdings Limited
- Amendment: SEC Form SCHEDULE 13G/A filed by EUDA Health Holdings Limited
- SEC Form 6-K filed by EUDA Health Holdings Limited
- SEC Form 6-K filed by EUDA Health Holdings Limited
- EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask
- EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
- SEC Form F-3 filed by EUDA Health Holdings Limited
- SEC Form 6-K filed by EUDA Health Holdings Limited
- SEC Form 20-F filed by EUDA Health Holdings Limited